LIXTE Biotech Advances Cancer Therapy with LB-100 Compound
March 23, 2026 — LIXTE Biotechnology advances cancer treatment with LB-100 compound designed to enhance immunotherapy and chemotherapy effectiveness through PP2A inhibition strategy.
NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
March 23, 2026 — LIXTE Biotechnology advances cancer treatment with LB-100 compound designed to enhance immunotherapy and chemotherapy effectiveness through PP2A inhibition strategy.
March 23, 2026 — Davis & Goldberg Orthodontics in High Point, NC offers advanced braces and Invisalign treatments with personalized care, state-of-the-art technology, and a focus on patient comfort and community engagement.
March 23, 2026 — Rawle Orthodontics in Lake Mary, FL offers premier clear aligner treatments for kids, teens, and adults using advanced technology and personalized care. Discover affordable, discreet orthodontic solutions today.
March 23, 2026 — Discover Kind Smiles Orthodontics & Pediatric Dentistry in Irvine, CA - offering gentle, comprehensive dental care for children & families with board-certified specialists.
March 23, 2026 — Esthetics Center introduces Candela GentleMax Pro laser for all skin types in Fair Oaks. Advanced dual-wavelength technology ensures safe, effective hair removal with inclusive treatments.
March 23, 2026 — Laser Center of Marin offers physician-supervised skincare treatments in Marin County for sun damage, acne, fine lines & more. Medical-grade solutions since 2003.
March 23, 2026 — Anne Therese Aesthetic Medicine introduces non-surgical facelift treatments in Lewis Center, Ohio, offering personalized, minimally invasive options for facial rejuvenation without surgery.
March 23, 2026 — Koch Orthodontics in Lawrenceville, GA offers expert braces and Invisalign treatment with a bilingual team and state-of-the-art technology for personalized care.
March 23, 2026 — Soligenix announces new HyBryte™ trial data for CTCL treatment, with presentations at a 2026 dermatology workshop. Learn about this breakthrough therapy and its impact on rare disease care.
March 23, 2026 — Study shows men make up only 5% of genetic cancer tests despite higher death rates and positive results. Research highlights a critical gender gap in preventive healthcare.
March 23, 2026 — Oncotelic Therapeutics subsidiary Sapu Nano presents new everolimus toxicology data at SOT 2026, highlighting tissue-level effects and nanoparticle delivery for improved cancer treatments.
March 23, 2026 — American Heart Association launches a nationwide initiative to improve early diagnosis and care for ATTR-CM, a life-threatening heart disease, with support from Alnylam Pharmaceuticals.
March 23, 2026 — BioStem Technologies appoints Jodi Ungrodt, a 29-year financial expert from Ernst & Young, to its Board as Audit Committee Chair to support growth and public market expansion in 2026.
March 23, 2026 — Mitch Gould of Nutritional Products International reflects on Chuck Norris's legacy in fitness and martial arts, connecting it to modern sports nutrition and recovery trends like KO Fitness Recovery Water.
March 20, 2026 — Co-Diagnostics expands CoSara joint venture across South Asia, targeting $13B market with PCR Pro® and SARAGENE® diagnostics platforms in Bangladesh, Pakistan, Nepal, Sri Lanka.
March 20, 2026 — Study finds teens who replace 30 minutes of sedentary time with physical activity reduce insulin resistance by 15%, lowering Type 2 diabetes risk. Research presented at American Heart Association conference.
March 20, 2026 — Co-Diagnostics' joint venture expands into Bangladesh, Pakistan, Nepal & Sri Lanka, targeting a $13B market for its PCR Pro point-of-care platform & SARAGENE diagnostics.
March 20, 2026 — Study of 300,000 adults finds elevated blood pressure in 30s-40s increases heart and kidney disease risk after 40. Early monitoring crucial for long-term health.
March 20, 2026 — Soligenix receives UK Promising Innovative Medicine designation for SGX945 to treat Behçet's disease, strengthening rare disease pipeline with regulatory recognition from MHRA.
March 20, 2026 — Calidi Biotherapeutics advances oncolytic virus therapy, a new cancer treatment using viruses to destroy tumors. BioMedWire reports on this transformative biomedical innovation.